CervoMed CRVO
NASDAQ CRVO
$1.87 +0.50 (+36.26%)
As of: Nov 11, 2026 · 11:31 AM EST

CervoMed (CRVO) Return on Equity [ROE] (2009 - 2026)

Updated

CervoMed (CRVO) posted Return on Equity [ROE] of -180.80% for Q2 2026, down 114.40 percentage points from -66.40% a year earlier but up 27.44 percentage points from the prior quarter.

Analysis

CervoMed (CRVO) Return on Equity [ROE] (2009 - 2026) Analysis & Trends

For FY2025, CervoMed's Return on Equity [ROE] came in at -93.89%, down 23.94 percentage points from FY2024.

  • Annual Return on Equity [ROE] shows a five-year change of -30.77 percentage points (FY2020 to FY2025).
  • In prior years, CervoMed's Return on Equity [ROE] was -69.94% in FY2024.
  • Quarterly Return on Equity [ROE] has run from a low of -1765.00% in Q1 2022 to a high of -24.98% in Q3 2024 over five years.
  • On a year-over-year basis, Return on Equity [ROE] has declined in each of the last five quarters, with an average year-over-year change of -44.25 percentage points over the last seven quarters.
  • The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q1 2025, with a gain of 86.56 percentage points; the weakest was Q1 2022, with a drop of 1723.52 percentage points.
  • According to Business Quant data, Return on Equity [ROE] for the three prior quarters was -208.24% (Q1 2026), -121.89% (Q4 2025) and -86.04% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 74.39%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 19.33%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 5.63%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 21.60%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 72.13%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -31.17%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 4.66%
10 CervoMed 20.73 Mn -57.60 Mn - -141.59%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -141.59%
Jun 30, 2026 -180.78%
Mar 31, 2026 -208.46%
Dec 31, 2025 -122.15%
Sep 30, 2025 -86.47%
Jun 30, 2025 -66.38%
Mar 31, 2025 -50.51%
Dec 31, 2024 -38.27%
Sep 30, 2024 -24.73%
Jun 30, 2024 -18.31%
Mar 31, 2024 -65.32%
Dec 31, 2023 -67.23%
Mar 31, 2022 627,263.01%
Dec 31, 2021 164,687.46%
Sep 30, 2021 -27,660.54%
Jun 30, 2021 -32.60%
Mar 31, 2021 -41.47%
Dec 31, 2020 -52.99%
Sep 30, 2020 -45.05%
Jun 30, 2020 -48.21%
API Access

CervoMed Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CRVO&period=max&api_key=YOUR_API_KEY